RMP
ABBV icon

Richards, Merrill & Peterson’s AbbVie ABBV Stock Holding History

Richards, Merrill & Peterson’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
7,403
+720
+11% +$155K 0.59% 41
2026
Q1 		$1.45M Buy
6,683
+96
+1% +$21.3K 0.53% 50
2025
Q4 		$1.5M Buy
6,587
+1,348
+26% +$307K 0.58% 43
2025
Q3 		$1.21M Buy
5,239
+182
+4% +$37.1K 0.52% 50
2025
Q2 		$939K Buy
5,057
+61
+1% +$11.3K 0.45% 62
2025
Q1 		$1.05M Buy
4,996
+22
+0.4% +$4.28K 0.54% 51
2024
Q4 		$884K Buy
+4,974
New +$915K 0.46% 57

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Richards, Merrill & Peterson's ABBV Position: Q2 2026 in Review

Richards, Merrill & Peterson increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $155K and bringing the position to 7,403 shares worth $1.86M. The position accounts for 0.59% of the portfolio, ranked #41.

Richards, Merrill & Peterson first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,899 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Richards, Merrill & Peterson held 7,403 shares of AbbVie worth $1.86M as of Q2 2026.
  • Richards, Merrill & Peterson bought 720 AbbVie shares in Q2 2026, an estimated $155K.
  • AbbVie made up 0.59% of Richards, Merrill & Peterson's portfolio in Q2 2026, its #41 holding.
  • Richards, Merrill & Peterson first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,899 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2026, filed 16 Jul 2026.